Eisai Ltd

European Knowledge Centre, Mosquito Way, Hatfield, Hertfordshire, AL10 9SN
Telephone: +44 (0)845 676 1400
Fax: +44 (0)845 676 1486
WWW: http://www.eisai.co.uk
Medical Information e-mail: Lmedinfo@eisai.net
Out of Hours Telephone: +44 (0)845 676 1400

Patient Information Leaflet last updated on the eMC: 14/12/2010
PIL NeuroBloc 5000 U/ml solution for injection

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 14/12/2010 and displayed until Current
Reasons for adding or updating:
  • Change/addition of instructions for reconstitution and/ or administration
  • Change to information for healthcare professionals
  • Change to date of revision
  • Change to, or new, use for medicine
  • Change to warnings or special precautions for use
  • Change of contra-indications
  • Change to side-effects
  • Change to drug interactions
  • Change to information about pregnancy or lactation
  • Change to information about driving or using machinery
Updated on 07/08/2009 and displayed until 14/12/2010
Reasons for adding or updating:
  • Change to how the medicine works
  • Change to date of revision
Updated on 16/04/2009 and displayed until 07/08/2009
Reasons for adding or updating:
  • Change to date of revision
  • Change to storage instructions
Updated on 03/04/2009 and displayed until 16/04/2009
Reasons for adding or updating:
  • Change to date of revision
  • Change to MA holder contact details
Updated on 19/02/2009 and displayed until 03/04/2009
Reasons for adding or updating:
  • Change to Further Information section
  • Change to warnings or special precautions for use
  • Change to side-effects
Updated on 21/10/2008 and displayed until 19/02/2009
Reasons for adding or updating:
  • Change to Further Information section
  • Change to name of manufacturer
Updated on 25/01/2008 and displayed until 21/10/2008
Reasons for adding or updating:
  • New PIL for eMC ie a PIL for an existing product but one that is new to the eMC

Active Ingredients/Generics

 
   botulinum toxin type b